Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Operating Expenses | 9,570 | 6,114 | 4,937 | 4,213 | 4,508 |
| Operating Income | -9,570 | -6,114 | -4,937 | -4,213 | -4,508 |
| Interest Expense | 0 | 0 | 0 | 3 | 72 |
| Other Income | 66 | 115 | 199 | 46 | 28 |
| Pre-tax Income | -9,504 | -5,999 | -4,738 | -4,170 | -4,552 |
| Net Income Continuous | -9,504 | -5,999 | -4,738 | -4,170 | -4,552 |
| Net Income | $-9,504 | $-5,999 | $-4,738 | $-4,170 | $-4,552 |
| EPS Basic Total Ops | -0.96 | -0.60 | -0.72 | -0.60 | -0.84 |
| EPS Basic Continuous Ops | -0.94 | -0.59 | -0.74 | -0.58 | -0.83 |
| EPS Diluted Total Ops | -0.96 | -0.60 | -0.72 | -0.60 | -0.84 |
| EPS Diluted Continuous Ops | -0.94 | -0.59 | -0.74 | -0.58 | -0.83 |
| EBITDA(a) | $-9,562 | $-6,108 | $-4,871 | $-4,203 | $-4,493 |